Where do Personalized Health Technologies stand today?

Biotechnet Switzerland

Authors

  • Elsbeth Heinzelmann

DOI:

https://doi.org/10.2533/chimia.2018.657

Keywords:

Cancer precision medicine program, Car t cells, Data computing services, Immunotherapy, Metastatic lung cancer, Multiple sclerosis care, Prostate cancer

Abstract

In June 2018, experts met at ETH Zurich to discuss technological challenges in advanced cell systems, variant interpretation, novel therapeutics and the integration of clinical data. The translation of these technologies into innovative clinical approaches in oncology, immunology, infectious diseases, neurology and cardiology will be a challenge for the future. Detailed information at http://www.personalizedhealth.nexus.ethz.ch/
CHIMIA Vol. 72 No. 9 (2018): Organometallics and Catalysis

Downloads

Published

2018-09-01

How to Cite

[1]
E. Heinzelmann, Chimia 2018, 72, 657, DOI: 10.2533/chimia.2018.657.

Issue

Vol. 72 No. 9 (2018): Organometallics and Catalysis

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2018 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.